Phase i randomized clinical trial of vrc dna and rad5 hiv-1 vaccine delivery by intramuscular (im), subcutaneous (sc) and intradermal (id) administration (vrc 011)

HIGHLIGHTS

• who: Subcutaneous (SC and colleagues from the Editor: Paul AGoepfert, University of Alabama, United States of America have published the paper: Phase I Randomized Clinical Trial of VRC DNA and rAd5 HIV-1 Vaccine Delivery by Intramuscular (IM), Subcutaneous (SC) and Intradermal (ID) Administration (VRC 011), in the Journal: PLOS ONE | www.plosone.org of March/12,/2014
• what: The authors report comparison of the IM (SC) and_(ID) routes of Methods: Sixty subjects were randomized to 6 schedules to evaluate the IM or route for prime injections. At the same time that plans were . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.